Aspergillus-induced superoxide production by cystic fibrosis phagocytes is associated with disease severity
| dc.contributor.author | Brunel, Shan F. | |
| dc.contributor.author | Willment, Janet A. | |
| dc.contributor.author | Brown, Gordon D. | |
| dc.contributor.author | Devereux, Graham | |
| dc.contributor.author | Warris, Adilia | |
| dc.contributor.institution | University of Aberdeen.Medicine, Medical Sciences & Nutrition | en |
| dc.contributor.institution | University of Aberdeen.Applied Medicine | en |
| dc.contributor.institution | University of Aberdeen.MRC Centre for Medical Mycology | en |
| dc.contributor.institution | University of Aberdeen.Grampian Data Safe Haven (DaSH) | en |
| dc.contributor.institution | University of Aberdeen.Institute of Applied Health Sciences | en |
| dc.date.accessioned | 2018-04-10T13:44:07Z | |
| dc.date.available | 2018-04-10T13:44:07Z | |
| dc.date.issued | 2018-04 | |
| dc.description | We would like to thank the CF patients for their participation and a special thank you goes to CF nurses Karen Griffiths and Sandra Steele (Aberdeen Royal Infirmary, Aberdeen, UK) for their invaluable contribution to this study. Support statement: A. Warris, G.D. Brown, S.F. Brunel and J.A. Willment were supported by the Wellcome Trust Strategic Award (grant 097377) and the MRC Centre for Medical Mycology (grant MR/N006364/1) at the University of Aberdeen. A. Warris and S.F. Brunel were also supported by the Chloe Fund. Funding information for this article has been deposited with the Crossref Funder Registry. | en |
| dc.description.status | Peer reviewed | en |
| dc.format.extent | 11 | |
| dc.format.extent | 707663 | |
| dc.identifier | 115757128 | |
| dc.identifier | 88245917-df6f-4e5a-a9e3-9b8c92323c90 | |
| dc.identifier | 29651422 | |
| dc.identifier | 85081958297 | |
| dc.identifier.citation | Brunel, S F, Willment, J A, Brown, G D, Devereux, G & Warris, A 2018, 'Aspergillus-induced superoxide production by cystic fibrosis phagocytes is associated with disease severity', ERJ Open Research, vol. 4, no. 2, 00068-2017, pp. 1-11. https://doi.org/10.1183/23120541.00068-2017 | en |
| dc.identifier.doi | 10.1183/23120541.00068-2017 | |
| dc.identifier.iss | 2 | en |
| dc.identifier.issn | 2312-0541 | |
| dc.identifier.other | ORCID: /0000-0002-7040-0857/work/59831248 | |
| dc.identifier.uri | http://hdl.handle.net/2164/10316 | |
| dc.identifier.vol | 4 | en |
| dc.language.iso | eng | |
| dc.relation.ispartof | ERJ Open Research | en |
| dc.subject | R Medicine (General) | en |
| dc.subject | Wellcome Trust | en |
| dc.subject | 097377 | en |
| dc.subject | Medical Research Council (MRC) | en |
| dc.subject | MR/N006364/1 | en |
| dc.subject.lcc | R1 | en |
| dc.title | Aspergillus-induced superoxide production by cystic fibrosis phagocytes is associated with disease severity | en |
| dc.type | Journal article | en |
